Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.805 USD | -0.14% | +8.91% | -60.57% |
29/04 | Gritstone Bio, Inc. Announces Board Changes | CI |
15/04 | Nature Medicine Publishes Interim Results from Gritstone Bio's Phase 1/2 Study of "Off-The-Shelf" Neoantigen Vaccine Platform | CI |
Business Summary
Number of employees: 231
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Vaccine-based Immunotherapy
100.0
%
| 20 | 100.0 % | 16 | 100.0 % | -18.05% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 20 | 100.0 % | 16 | 100.0 % | -18.05% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Andrew Allen
FOU | Founder | 57 | 01/15/01 |
Director of Finance/CFO | 44 | 23/21/23 | |
Karin Jooss
CTO | Chief Tech/Sci/R&D Officer | 59 | 13/16/13 |
Erin Jones
COO | Chief Operating Officer | 52 | 01/16/01 |
Investor Relations Contact | - | 01/21/01 | |
James Cho
AUD | Comptroller/Controller/Auditor | - | 01/19/01 |
Human Resources Officer | - | - | |
Matthew Hawryluk
PRN | Corporate Officer/Principal | 46 | 01/15/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Allen
FOU | Founder | 57 | 01/15/01 |
Elaine Jones
CHM | Chairman | 69 | 12/19/12 |
Lawrence Corey
BRD | Director/Board Member | 77 | 12/22/12 |
Steve Krognes
BRD | Director/Board Member | 56 | 10/18/10 |
Naiyer Rizvi
FOU | Founder | 60 | - |
Shefali Agarwal
BRD | Director/Board Member | 50 | 01/21/01 |
Clare Fisher
BRD | Director/Board Member | 51 | 01/22/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 105,918,748 | 103,482,823 ( 97.70 %) | 0 | 97.70 % |
Company contact information
Gritstone bio, Inc.
5959 Horton Street Suite 300
94608, Emeryville
+510 871 6100
http://www.gritstonebio.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.57% | 85.77M | |
-3.45% | 87.17B | |
+1.97% | 40.1B | |
-17.16% | 31.38B | |
+57.98% | 25.12B | |
-15.92% | 15.59B | |
-8.82% | 12B | |
-41.58% | 11.8B | |
-16.11% | 11.8B | |
+6.89% | 8.81B |
- Stock Market
- Equities
- GRTS Stock
- Company Gritstone bio, Inc.